These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 5536050)

  • 1. [Late extrapyramidal hyperkineses after prolonged neuroleptic therapy].
    Hippius H; Lange J
    Arzneimittelforschung; 1970 Jul; 20(7):888-90. PubMed ID: 5536050
    [No Abstract]   [Full Text] [Related]  

  • 2. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa; Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract]   [Full Text] [Related]  

  • 3. [The semiology of motor function disorders during treatment with neuroleptic drugs].
    Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(12):1798-804. PubMed ID: 5511943
    [No Abstract]   [Full Text] [Related]  

  • 4. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].
    Degkwitz R; Bauer MP; Gruber M; Hampel G; Luxenburger O; Richartz M; Wenzel W
    Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].
    Hippius H; Logemann G
    Arzneimittelforschung; 1970 Jul; 20(7):894-6. PubMed ID: 5536051
    [No Abstract]   [Full Text] [Related]  

  • 6. [Late irreversible extrapyramidal syndrome following neuroleptic use].
    Boucebci M
    Acta Psychiatr Belg; 1972 Mar; 72(2):233-40. PubMed ID: 5056017
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extrapyramidal accidents in outpatient therapy].
    Rouleau Y
    Laval Med; 1970 Sep; 41(7):906-8. PubMed ID: 5509488
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the problem of the terminal extrapyramidal hyperkineses as observed in 1600 patients during long-term therapy with neuroleptics].
    Degkwitz R; Wenzel W; Binsack KF; Herkert H; Luxenburger O
    Arzneimittelforschung; 1966 Feb; 16(2):276-9. PubMed ID: 4861657
    [No Abstract]   [Full Text] [Related]  

  • 10. [Causes of persisting extrapyramidal hyperkinesis after prolonged administration of major tranquilizers].
    Degkwitz R
    Act Nerv Super (Praha); 1967 Nov; 9(4):389-400. PubMed ID: 5612952
    [No Abstract]   [Full Text] [Related]  

  • 11. [Persistent extrapyramidal oral dyskinesia following administration of thymoleptics].
    Sedivec V; Valenová Z; Paceltová L
    Cesk Psychiatr; 1969 Aug; 65(4):241-4. PubMed ID: 5807247
    [No Abstract]   [Full Text] [Related]  

  • 12. [Extrapyramidal hyperkineses following prior cerebral damage and long-term therapy using neuroleptics: ballistic syndrome, "hysteroid" attacks and hyopharyngeal syndrome with special reference to the clinical picture: misdiagnosis of the disorders as psychogenic and schizophrenic symptoms].
    Meyendorf R
    Schweiz Arch Neurol Neurochir Psychiatr; 1969; 105(1):165-76. PubMed ID: 4903648
    [No Abstract]   [Full Text] [Related]  

  • 13. A survey of extrapyramidal manifestations in patients attending an after care clinic of a psychiatric hospital.
    Guttman H; Lehmann HE; Ban TA
    Laval Med; 1970 Apr; 41(4):449-55. PubMed ID: 5515661
    [No Abstract]   [Full Text] [Related]  

  • 14. [Paroxysmal extrapyramidal syndrome caused by taking neuroleptic drugs].
    Gurovich IIa; Fleĭs EP
    Klin Med (Mosk); 1969 Sep; 47(9):132-7. PubMed ID: 5397873
    [No Abstract]   [Full Text] [Related]  

  • 15. [Complex persisting dyskinesia, secondary to neuroleptic therapy].
    Castaigne P; Lapresle J; Chain F
    Rev Neurol (Paris); 1969 Mar; 120(3):215-9. PubMed ID: 5343991
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
    Haddenbrock S
    Nervenarzt; 1966 May; 37(5):199-203. PubMed ID: 5298253
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transitory exacerbations arising during the course of neuroleptic therapy].
    Gurovich IIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(6):919-25. PubMed ID: 5471621
    [No Abstract]   [Full Text] [Related]  

  • 18. [Orolingual dyskinesia caused by prolonged neuroplegic therapy].
    Fenyvesi T
    Orv Hetil; 1968 Sep; 109(39):2149-52. PubMed ID: 5716904
    [No Abstract]   [Full Text] [Related]  

  • 19. [Post-neuroleptic late dyskinesia].
    Villeneuve A; Lavallée JC; Lemieux LH
    Laval Med; 1969 Nov; 40(9):832-7. PubMed ID: 5366584
    [No Abstract]   [Full Text] [Related]  

  • 20. [Extrapyramidal motor disorders in children as a side effect of therapy with neuroleptics and the new antiemetic metoclopramide].
    Witzel K
    Arch Kinderheilkd; 1968 Sep; 177(3):277-83. PubMed ID: 5716215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.